Closing Conditions Clause

TL;DR: A closing conditions clause in an M&A purchase agreement (SPA, APA, or merger agreement) lists the prerequisites that must be satisfied or waived before either party is obligated to close. Standard categories include the bring-down of representations and warranties, performance of pre-closing covenants, absence of a Material Adverse Effect, receipt of regulatory approvals (HSR, CFIUS, foreign FDI), required third-party consents, and delivery of closing deliverables (officer's and secretary's certificates, legal opinions, payoff letters, FIRPTA, R&W insurance binder). The drafting allocates interim risk between signing and closing, sets the threshold for a buyer's walk-away right, and largely determines deal certainty. Get the bring-down standard, MAE qualifier, and regulatory effort wrong and a buyer ends up either forced to close a broken deal or handing the seller a free option to retrade.

‍

What Is a Closing Conditions Clause?

A closing conditions clause is the section of an acquisition agreement (typically Article VII or VIII in a market-form SPA) that enumerates the conditions to each party's obligation to consummate the closing. It is structured in three parts: mutual conditions (no injunction, expiration of HSR waiting periods, stockholder approval in a public deal); buyer's conditions (accuracy of seller's representations, performance of seller's covenants, no MAE, delivery of seller's closing deliverables); and seller's conditions (accuracy of buyer's representations, performance of buyer's covenants, delivery of the purchase price and buyer's deliverables). If a condition is not satisfied or waived by the outside date, the agreement typically gives one or both parties the right to terminate.

The clause works in tandem with several interlocking provisions: the representations and warranties (referenced by the bring-down), the interim covenants, the MAE definition, the regulatory cooperation covenant and effort standard, the termination provisions, and the indemnification provisions. Read in isolation, the closing conditions clause is meaningless; it must be analyzed alongside these provisions.

In a sign-and-close deal, conditions are minimal. In a deferred-closing deal (the standard for any transaction requiring HSR notification, CFIUS review, FDI clearance, third-party consents, or stockholder approval), the clause is the most heavily negotiated section. The ABA Private Target M&A Deal Points Study tracks the frequency and formulation of each category of closing condition.

‍

Why It Matters

• Deal certainty vs. optionality: A buyer's closing conditions are, in economic substance, a portfolio of options to walk. The narrower the conditions, the higher the seller's certainty of close. In a competitive auction, sellers explicitly score bids on certainty of close, and a bid with broad subjective conditions (financing out, expansive MAE, lengthy consent list) is routinely discounted relative to a tighter bid even at a lower headline price.
• Interim risk allocation: Closing conditions allocate the risk of interim events between signing and closing. A no-MAE condition allocates the risk of material business deterioration to the seller. A bring-down at "true and correct in all respects" allocates the risk of any factual change to the seller; a bring-down at "in all material respects" allocates that risk to the buyer.
• Regulatory and third-party dependencies: Most US M&A deals above the HSR size-of-transaction threshold (15 U.S.C. Section 18a; the 2026 threshold is approximately $126.4 million as adjusted by the FTC) require pre-merger notification and a 30-day waiting period. Deals involving foreign acquirers of US businesses with national security implications may require CFIUS review under 31 C.F.R. Part 800. Cross-border deals may trigger FDI screening in the EU, UK, Germany, France, and elsewhere.
• Termination and break fees: Failure of a condition that cannot be cured by the outside date typically gives one or both parties the right to terminate. The economic consequences (no fee, target break fee, reverse termination fee, or specific performance) depend on which condition failed and why. Reverse termination fees in PE deals frequently track the failure of regulatory or financing-related conditions.
• Bring-down standard drives MAE leverage: The bring-down standard is functionally a second MAE condition. A bring-down at "true and correct ignoring materiality qualifiers, except where the failure would not be reasonably expected to have an MAE" gives the buyer a walk right whenever an aggregate breach of representations would constitute an MAE - often easier to satisfy than the standalone no-MAE condition because it aggregates breaches across all reps rather than requiring proof of MAE on the business as a whole.

‍

Key Elements of a Well-Drafted Closing Conditions Clause

1. Bring-down of representations and warranties: A condition that the other party's representations be true and correct as of the closing date. Negotiation centers on three variables: the accuracy standard ("in all respects," "in all material respects," or "except as would not constitute an MAE"); whether embedded materiality qualifiers are scraped; and whether fundamental reps (organization, authority, capitalization, no-conflicts) are subject to a stricter standard than business reps. The market-standard formulation pairs fundamental reps at "true and correct" subject to de minimis, with business reps subject to materiality scrape plus MAE backstop.
2. Performance of pre-closing covenants: A condition that the other party has performed its pre-closing covenants in all material respects. This covers ordinary-course operating covenants, specific affirmative obligations (obtaining listed consents, regulatory filings), and prohibitive covenants (no dividends, no acquisitions, no indebtedness above a threshold).
3. No MAE since signing: A condition that no Material Adverse Effect has occurred between signing and closing. Although MAE invocation has historically faced an extremely high bar in Delaware (Akorn v. Fresenius (Del. Ch. 2018) remains the only Delaware decision finding an MAE that justified termination), the no-MAE condition retains substantial leverage value as a renegotiation tool. The MAE definition itself is usually the single most heavily lawyered definition in the agreement.
4. Required regulatory approvals: Conditions tied to receipt or expiration of specified regulatory approvals. The HSR condition (30-day waiting period for cash deals) is mutual. CFIUS conditions require receipt of clearance or expiration of the review period. FDI conditions require clearance from the relevant foreign regulator. The buyer's effort standard ranges from "commercially reasonable efforts" through "reasonable best efforts" to a "hell or high water" commitment requiring divestitures or behavioral remedies.
5. Required third-party consents: Conditions tied to specified third-party consents, typically limited to assignment of material contracts, real property leases, IP licenses, or change-of-control consents under credit facilities or JV agreements. Negotiation centers on the scope of the list (all material contracts vs. an agreed schedule), the standard for satisfaction, and what happens if a consent fails.
6. Delivery of closing deliverables: Standard seller deliverables include: officer's certificate confirming bring-down and covenant compliance; secretary's certificate attaching resolutions, charter, bylaws, and good standing certificates; legal opinion of seller's counsel; payoff letters and lien releases for repaid indebtedness; FIRPTA non-foreign affidavit (Treasury Regulation Section 1.1445-2(b)(2)); resignations of directors and specified officers; ancillary agreements (TSA, employment agreements, restrictive covenant agreements, escrow agreement); and the R&W insurance policy or binder.
7. No injunction or legal prohibition: A mutual condition that no governmental order, injunction, or law prohibits or makes illegal the consummation of the transaction. This is typically not waivable unilaterally because closing in violation of a court order exposes both parties to liability. The condition is usually drafted to require an order in effect at closing rather than a mere risk of one.
8. Stockholder approval (where applicable): Receipt of the requisite vote is a mutual condition in public deals and private deals where the seller is a corporation requiring approval. In private deals, the condition is often satisfied by written consent delivered concurrently with signing, eliminating it. In public deals, the condition runs from proxy filing through the stockholder meeting, typically two to four months after signing.

‍

Market Position & Benchmarks

Where Does Your Clause Fall?

• Buyer-Favorable: Bring-down at "true and correct in all respects" with full materiality scrape, no-MAE condition with a narrow MAE definition, expansive third-party consent list, financing condition (rare), buyer's regulatory commitment limited to "commercially reasonable efforts," all conditions waivable by buyer in its sole discretion.
• Market Standard: Bring-down with materiality scrape and MAE backstop (representations true and correct disregarding materiality qualifiers, except where the failure would not reasonably be expected to result in an MAE; fundamental reps subject to de minimis threshold); covenants performed in all material respects; standard MAE definition with carve-outs for general economic conditions, industry-wide changes, changes in law and accounting, effects of the announced transaction, pandemics, and acts of war or terrorism (with disproportionate-impact exceptions); regulatory approvals as mutual conditions; reasonable best efforts on regulatory; no financing condition; consents limited to a defined schedule.
• Seller-Favorable: Bring-down at "in all material respects" with embedded MAE qualifier preserved (no scrape), narrow consent list (typically credit facility and a handful of named contracts), "hell or high water" or specified-divestiture commitment from buyer on regulatory approvals, reverse termination fee payable on regulatory failure or buyer breach, MAE definition with broad carve-outs and tight disproportionate-impact tests.

Market Data

• Per the 2023 ABA Private Target M&A Deal Points Study, approximately 100% of private-target deals included a bring-down condition, and 99% included a covenant compliance condition.
• The same study found approximately 95% of private-target deals included a no-MAE closing condition, with the bring-down qualified by an MAE standard in approximately 76% of deals (up from 69% in 2021).
• A materiality scrape appeared in approximately 64% of deals in the 2023 ABA study, with the buyer-favorable "double scrape" (applied to both the closing condition and indemnification) in approximately 42%.
• HSR Act notification was required in approximately 70% of private-target deals in the 2023 ABA study; HSR clearance is universally a mutual closing condition where applicable.
• Financing conditions appeared in only 1% of private-target deals in the 2023 ABA study, down from 3% in 2021. Buyers bear financing risk via reverse termination fees, typically 4 to 8 percent of equity value in PE-sponsored deals.
• "Hell or high water" or other heightened regulatory effort obligations appeared in approximately 13% of deals in the 2023 ABA study, with another 22% requiring divestiture of specified assets up to a defined threshold.
• R&W insurance was used in approximately 65% of private-target deals in the 2023 ABA study (up from 52% in 2017); where used, delivery of the bound policy or binder is a near-universal closing condition.

Sample Language by Position

Buyer-Favorable: "The obligations of Buyer to consummate the Closing are subject to (or waiver in writing by Buyer in its sole discretion): (a) each representation of the Seller shall be true and correct in all respects as of the date hereof and as of the Closing Date; (b) the Seller shall have performed in all respects each of its covenants required to be performed at or prior to the Closing; (c) since the date hereof, no event shall have occurred that has had or would reasonably be expected to have a Material Adverse Effect; and (d) all consents set forth on Schedule 7.1(d) shall have been obtained on terms reasonably satisfactory to Buyer."

Market Standard: "The obligations of Buyer to consummate the Closing are subject to (or waiver by Buyer): (a)(i) the Fundamental Representations shall be true and correct in all respects (other than de minimis inaccuracies) as of the Closing Date; (ii) all other representations (disregarding qualifications as to materiality or Material Adverse Effect) shall be true and correct as of the Closing Date, except where the failure would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect; (b) the Seller shall have performed in all material respects its covenants required to be performed at or prior to the Closing; (c) since the date hereof, no Material Adverse Effect shall have occurred and be continuing; (d) any waiting period under the HSR Act shall have expired or been earlier terminated; and (e) the Seller shall have delivered an officer's certificate certifying as to (a), (b), and (c)."

Seller-Favorable: "The obligations of Buyer to consummate the Closing are subject to: (a) the representations (giving effect to qualifications as to materiality and Material Adverse Effect) shall be true and correct in all material respects as of the Closing Date; (b) the Seller shall have performed in all material respects its covenants required to be performed at or prior to the Closing; (c) since the date hereof, no Material Adverse Effect shall have occurred and be continuing; and (d) any waiting period under the HSR Act shall have expired. For the avoidance of doubt, receipt of any third-party consent shall not be a condition to Buyer's obligation to consummate the Closing."

‍

Example Clause Language

SPA (Mutual Conditions): "The respective obligations of each Party to consummate the Closing are subject to: (a) any waiting period under the HSR Act shall have expired or been earlier terminated; (b) any clearance from CFIUS shall have been obtained or the applicable review period shall have expired without action; (c) no Governmental Authority shall have enacted any Law or Order in effect on the Closing Date making the consummation illegal or otherwise prohibiting consummation; and (d) the Required Stockholder Approval shall have been obtained."

APA (Seller's Closing Deliverables): "The Seller shall have delivered to Buyer: (a) a duly executed Bill of Sale and Assignment and Assumption Agreement; (b) assignments of all registered Intellectual Property; (c) an officer's certificate certifying that the conditions in Sections 7.2(a), (b), and (c) have been satisfied; (d) a secretary's certificate certifying the resolutions authorizing the transactions, the certificate of incorporation and bylaws, and the incumbency of officers; (e) a certificate of good standing dated within ten Business Days of the Closing Date; (f) an opinion of Seller's counsel; (g) Payoff Letters with UCC-3 termination statements; (h) a FIRPTA certificate in the form set forth in Treasury Regulation Section 1.1445-2(b)(2)(iv)(B); (i) resignations from each director and officer set forth on Schedule 7.2(i); and (j) the Transition Services Agreement, Escrow Agreement, Restrictive Covenant Agreements, and each other Ancillary Document."

Public Merger Agreement (Tiered Bring-Down): "The obligation of Parent and Merger Sub to effect the Merger is subject to: (a) the representations in Sections 4.1 (Organization), 4.2 (Capitalization), 4.3 (Authority), and 4.20 (Brokers) shall be true and correct in all but de minimis respects; (b) the other representations in Article IV (disregarding qualifications as to materiality or Material Adverse Effect) shall be true and correct as of the Closing Date, except where the failure would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; (c) the Company shall have performed in all material respects its covenants required to be performed on or prior to the Closing Date; (d) since the date hereof, no Material Adverse Effect that is continuing shall have occurred; and (e) Parent shall have received an executive officer's certificate certifying as to clauses (a) through (d)."

‍

Common Contract Types

• Stock Purchase Agreements (SPAs): Closing conditions are the structural backbone of any private-target SPA with a deferred closing.
• Asset Purchase Agreements (APAs): APAs typically have more extensive third-party consent conditions than SPAs because asset transfers trigger consents not triggered by equity transfers (no change of control occurs in an asset deal).
• Merger Agreements (Public and Private): Include stockholder approval (in public deals), proxy/Schedule 14A clearance from the SEC, and listing conditions (in stock-for-stock deals).
• Tender Offer Agreements: Conditions operate at the tender offer's expiration; the minimum tender condition (typically 50% or two-thirds of outstanding shares) is the central condition unique to tender offers.
• Joint Venture Formation Agreements: Conditions to formation of the JV entity and initial capital contributions, including regulatory approvals, IP assignments from contributing partners, and execution of the operating/shareholders agreement.
• Carve-Out Transactions: Additional conditions tied to legal separation, including formation of the new entity, contribution of carved-out assets and liabilities, and TSA execution.
• Investment and Subscription Agreements: Conditions tied to delivery of share certificates, amended charter, investor rights agreement, voting agreement, ROFR/co-sale agreement, and management certifications.
• Real Estate Purchase and Sale Agreements: Conditions focus on title clearance, environmental assessments, zoning approvals, financing contingencies, tenant estoppels and SNDA delivery, and physical inspection contingencies.

‍

Negotiation Playbook

Key Drafting Notes

• Calibrate the bring-down standard: The market default is "true and correct except as would not constitute an MAE" with materiality scrape, but the right standard depends on deal dynamics. In a competitive auction, sellers can push for "in all material respects" with the embedded MAE qualifier preserved (no scrape). Layer the structure: fundamental reps (organization, authority, capitalization, brokers) at the strict standard with de minimis carve-out; tax and ERISA reps at an intermediate standard; business reps at the MAE-qualified standard.
• Distinguish mutual from unilateral conditions: Conditions that protect both parties (no injunction, regulatory approvals, stockholder approval) should be mutual. Conditions that protect only one party (accuracy of the counterparty's reps, performance of its covenants) should be unilateral and waivable by the benefiting party. Never let a party refuse to close based on its own failure to satisfy a condition within its control.
• Define the regulatory effort standard with precision: Generic "reasonable best efforts" obligations are notoriously hard to enforce. If the deal involves significant antitrust risk, supplement with specific behavioral commitments: a "reasonable best efforts" floor combined with obligations to take or accept identified actions (divest the overlapping business unit, accept a behavioral remedy, litigate against a Second Request). Channel Medsystems v. Boston Scientific (Del. Ch. 2019) and the Cooper Tire/Apollo cases illustrate how disputes over regulatory effort obligations get litigated.
• Address the gap with interim covenants: Closing conditions only operate at closing and do not in themselves prevent interim changes. Pair them with interim operating covenants (ordinary course, no extraordinary actions, prohibitions on specific categories) and information rights. Without supporting interim covenants, the closing conditions clause is a fire alarm without sprinklers.
• Draft waiver mechanics with care: Specify that any waiver must be in writing, that waiver of one condition is not a waiver of any other, that partial waiver is not a complete waiver, and that waiver of a closing condition does not waive the underlying breach for indemnification purposes. The interaction between waiver and indemnification is the most commonly missed drafting issue.
• Coordinate with the outside date: The outside date should provide runway to satisfy all conditions, particularly regulatory ones where HSR Second Requests can extend review by 6-12 months and CFIUS review by 90+ days. Build in automatic outside date extensions if the only unsatisfied condition is regulatory clearance and the parties remain actively engaged with the regulator.

Common Pitfalls

• Including a financing condition in a competitive process: A financing condition allows the buyer to walk if it cannot obtain financing. This is essentially extinct in private-target deals (1% in the 2023 ABA study) and signals to sellers that the bid is not bankable. The market alternative is a reverse termination fee, typically 4-8% of equity value in PE deals.
• Loose MAE definition that swallows the no-MAE condition: A no-MAE condition is only as protective as the underlying MAE definition. An MAE definition with broad carve-outs (general economic conditions, industry-wide changes, changes in law, effects of the announced transaction, pandemics, acts of war), no disproportionate-impact tests, and exclusion of forward-looking forecasts may give the buyer no walk right at all. Akorn v. Fresenius (Del. Ch. 2018) remains the only Delaware MAE walkaway, with the bar including quantitative thresholds (typically 20%+ EBITDA decline year-over-year) and durational significance (multiple quarters of expected continued impact, per IBP v. Tyson (Del. Ch. 2001)).
• Open-ended third-party consent conditions: A buyer-favorable formulation requires "all required consents" without a defined list. This converts every undisclosed consent requirement into a buyer walk right, which in practice no seller can deliver against. The market standard is a defined schedule of "Required Consents" (usually 5-15 contracts representing the most material customer agreements, key real estate leases, and indebtedness change-of-control provisions).
• Bring-down certificate signed by an officer without knowledge: The officer's certificate certifies that the bring-down conditions have been satisfied. In a sale of a closely-held business, the certifying officer is typically the founder or CEO with personal knowledge. In a corporate carve-out, the certifying officer may be a divisional executive with limited knowledge of the divested business's representations. Match the certifying officer to the certification scope.
• Ignoring waiver/indemnification interaction: A buyer that waives a closing condition (e.g., waives an inaccurate representation to allow the closing to proceed) may be deemed to have waived its indemnification rights for the underlying breach. This is the sandbagging issue. The buyer's protective drafting is a pro-sandbagging provision preserving claims even where the buyer had knowledge or waived the condition; the seller's pushback is an anti-sandbagging provision extinguishing claims for matters known to the buyer pre-closing.
• Failure to address frustration: If the buyer's failure to use reasonable best efforts on regulatory clearance contributed to the regulatory condition's failure, can the buyer still terminate? Include a frustration-of-purpose provision barring a party from terminating based on a condition whose failure was caused by that party's own breach of covenant.

‍

Jurisdiction Notes

• U.S.: Delaware law governs the substantial majority of US M&A transactions and provides the most developed body of case law on closing conditions. The seminal MAE case is IBP v. Tyson Foods (Del. Ch. 2001), holding that a buyer invoking an MAE must demonstrate effects that are durationally significant and material to the target's long-term earning power. Akorn v. Fresenius (Del. Ch. 2018) remains the only Delaware decision finding a buyer was justified in terminating based on MAE, with Vice Chancellor Laster finding both an MAE and a separate failure of regulatory representations after a 35% decline in EBITDA combined with FDA data integrity issues. Channel Medsystems v. Boston Scientific (Del. Ch. 2019) addresses the interaction between fraud, the bring-down condition, and the buyer's obligation to close in the face of allegedly inaccurate representations. The HSR Act (15 U.S.C. Section 18a) governs pre-merger antitrust notification with a 30-day initial waiting period; Second Requests can extend review by months. CFIUS regulations (31 C.F.R. Part 800 for covered transactions and Part 802 for real estate) govern foreign investment review under FIRRMA.
• U.K.: English law treats closing conditions as conditions precedent to performance and applies a contractual good-faith standard (narrower than Delaware's) to a party's obligation to satisfy conditions within its control. The leading English MAC case is Grupo Hotelero Urvasco v. Carey Value Added (2013 EWHC 1039 (Comm)), which adopted a similar high-bar standard to Delaware. UK regulatory conditions include CMA antitrust review and National Security and Investment Act 2021 mandatory notification for transactions in 17 sensitive sectors. The Takeover Code imposes prescriptive rules on the waivability of conditions in public takeover offers, including a near-prohibition on subjective MAC conditions.
• Other: Civil law jurisdictions (Germany, France, the Netherlands) treat closing conditions as statutorily defined concepts with codified good-faith requirements (BGB Section 162 in Germany; Code Civil Article 1304-3 in France) deeming a condition fulfilled if a party prevented its satisfaction in bad faith. Cross-border M&A increasingly requires multiple FDI approvals (Germany AWG/AWV, France IEF, Italy Golden Power, Australia FIRB, EU-level review under Regulation (EU) 2019/452).

‍

Related Clauses

• Conditions Precedent - Closing conditions are the principal application of the conditions precedent doctrine in M&A purchase agreements.
• Material Adverse Change - The no-MAC/MAE condition is the buyer's primary protection against deterioration of the target's business between signing and closing.
• Material Adverse Effect - The MAE qualifier appears in both the bring-down condition (as a backstop to the accuracy standard) and the standalone no-MAE condition.
• Representations and Warranties - The bring-down of representations to the closing date is the most universally included closing condition (100% of deals in the 2023 ABA study).
• Sandbagging Clause - Pro-sandbagging and anti-sandbagging provisions interact with the closing conditions clause, determining whether a buyer that waives a condition retains its indemnification rights for the underlying breach.
• No-Shop Clause - The no-shop covenant operates during the same signing-to-closing interim period that the closing conditions clause governs.
• Termination Fee - Target break fees and reverse termination fees are triggered by the failure of closing conditions, allocating the economic risk of a failed closing.

‍

This glossary entry is provided for informational and educational purposes only. It does not constitute legal advice, and no attorney-client relationship is formed by reading this content. Closing conditions involve interlocking provisions across the purchase agreement, ancillary documents, regulatory filings, and disclosure schedules. Consult qualified M&A counsel in the relevant jurisdiction before drafting, negotiating, or invoking closing conditions in any acquisition agreement.